trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Treatments for chronic kidney disease include hypertension control, diabetes control, lipid control, and the use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that treatments for chronic kidney disease include hypertension control, diabetes control, lipid control, and the use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers?

Yes. Treatments for chronic kidney disease consistently involve managing hypertension, diabetes, and lipid levels alongside the use of renin-angiotensin system inhibitors such as ACE inhibitors or ARBs.

Verdict: SUPPORTED · 2 sources for, 0 against · Last checked

The analysis

The retrieved papers provide strong supportive evidence that standard treatment approaches for chronic kidney disease include hypertension control, diabetes control, lipid control, and renin-angiotensin-aldosterone system inhibition (such as ACEis or ARBs). None of the papers refute this claim.

Evidence for · 2
2026
Get citation
T, N., L, H., & T, I. (2026). Preventing Cardiovascular-Kidney-Metabolic Syndrome Progression: Pharmacologic Approaches and Pharmacists' Contributions.. doi.org. https://doi.org/10.1159/000552517

See more details
More for · 1
2026
Get citation
MD, A., A, V., M, Q., M, A., H, K., MF, A. J., S, M., AF, W., S, T., & M, E. (2026). Translational advances in diabetic nephropathy management: integrating nanoformulation-based drug delivery systems.. doi.org. https://doi.org/10.3389/fmedt.2026.1951734

What does the evidence say?

The retrieved papers provide strong supportive evidence that standard treatment approaches for chronic kidney disease include hypertension control, diabetes control, lipid control, and renin-angiotensin-aldosterone system inhibition (such as ACEis or ARBs). None of the papers refute this claim.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work